2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Dual Labeling Biotin Switch Assay to Reduce Bias Derived from Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rationale

          S-nitrosylation (SNO), an oxidative post-translational modification of cysteine residues, responds to changes in the cardiac redox-environment. Classic biotin switch assay and its derivatives are the most common methods used for detecting SNO. In this approach, the labile SNO group is selectively replaced with a single stable tag. To date, a variety of thiol-reactive tags have been introduced. However, these methods have not produced a consistent dataset which suggests an incomplete capture by a single tag and potentially the presence of different cysteine subpopulations.

          Objective

          To investigate potential labeling bias in the existing methods with a single tag to detect SNO, explore if there are distinct cysteine subpopulations, and then, develop a strategy to maximize the coverage of SNO proteome.

          Methods and Results

          We obtained SNO-modified cysteine datasets for wild-type and S-nitrosoglutathione reductase (GSNOR) knock-out mouse hearts (GSNOR is a negative regulator of GSNO production) and NO-induced human embryonic kidney cell using two labeling reagents; the cysteine-reactive pyridyldithiol and iodoacetyl based tandem mass tags. Comparison revealed that <30% of the SNO-modified residues were detected by both tags, while the remaining SNO sites were only labeled by one reagent. Characterization of the two distinct subpopulations of SNO residues indicated that pyridyldithiol reagent preferentially labels cysteine residues that are more basic and hydrophobic. Based on this observation, we proposed a parallel dual labeling strategy followed by an optimized proteomics workflow. This enabled the profiling of 493 SNO-sites in GSNOR knock-out hearts.

          Conclusions

          Using a protocol comprising two tags for dual labeling maximizes overall detection of SNO by reducing the previously unrecognized labeling bias derived from different cysteine subpopulations.

          Related collections

          Author and article information

          Journal
          0047103
          2974
          Circ Res
          Circ. Res.
          Circulation research
          0009-7330
          1524-4571
          14 May 2016
          03 September 2015
          23 October 2015
          23 October 2016
          : 117
          : 10
          : 846-857
          Affiliations
          [1 ]Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD, USA
          [2 ]Department of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA
          [3 ]The Johns Hopkins NHLBI Proteomics Innovation Center on Heart Failure, Johns Hopkins University, Baltimore, MD, USA
          [4 ]Mass Spectrometry and Proteomic Facility, Johns Hopkins University, Baltimore, MD, USA
          [5 ]Thermo Fisher Scientific, Rockford, IL, USA
          [6 ]Advanced Clinical Biosystems Research Institute, Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
          [7 ]Department of Medicine, Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA
          [8 ]Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada
          [9 ]Division of Cardiology, Medical University of Graz, Austria
          Author notes
          Address correspondence to: Dr. Jennifer E. Van Eyk, Advanced Health Science Pavilion Room A9307, 127 S. San Vicente Blvd., Cedars Sinai Medical Center, Los Angeles, CA 90048, Tel: 310-384-6674, Fax: 310-423-3522, Jennifer.VanEyk@ 123456cshs.org
          Article
          PMC4979977 PMC4979977 4979977 nihpa721123
          10.1161/CIRCRESAHA.115.307336
          4979977
          26338901
          877b4f85-3456-4a96-a344-d028d6bf354c
          History
          Categories
          Article

          S-nitrosylation,nitric oxide,biotin switch assay,tandem mass tag,proteomics,S-nitrosoglutathione reductase,oxidation,redox,Basic Science Research,Functional Genomics,Cell Signaling/Signal Transduction

          Comments

          Comment on this article